Sarepta Therapeutics (SRPT) Other Non-Current Assets (2010 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Other Non-Current Assets of $4.1 million for Q1 2026, down 73.55% year-over-year from $15.6 million in Q1 2025, and down 20.62% quarter-over-quarter from $5.2 million in Q4 2025.
Sarepta Therapeutics (SRPT) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $4.1 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 73.55% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 73.55% YoY), while the FY2025 annual figure was $5.2 million, up 354.47% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $4.1 million, down from $5.2 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $278.6 million in Q1 2022, with the low at $1.1 million in Q4 2024.
- The 5-year median for Other Non-Current Assets is $5.2 million (2025), against an average of $47.6 million.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets jumped 13019.07% in 2022, then tumbled 99.17% in 2024.
- Sarepta Therapeutics' Other Non-Current Assets stood at $2.2 million in 2022, then jumped by 6261.44% to $136.8 million in 2023, then sank by 99.17% to $1.1 million in 2024, then jumped by 354.47% to $5.2 million in 2025, then fell by 20.62% to $4.1 million in 2026.
- Business Quant data shows SRPT's Other Non-Current Assets at $4.1 million in Q1 2026, $5.2 million in Q4 2025, and $73.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | 146.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 146.15 Mn |
| Mar 31, 2026 | 4.12 Mn |
| Dec 31, 2025 | 5.19 Mn |
| Sep 30, 2025 | 73.38 Mn |
| Jun 30, 2025 | 83.14 Mn |
| Mar 31, 2025 | 15.58 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 15.58 Mn |
| Jun 30, 2024 | 3.14 Mn |
| Mar 31, 2024 | 15.58 Mn |
| Dec 31, 2023 | 136.77 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 162.39 Mn |
| Dec 31, 2022 | 2.15 Mn |
| Sep 30, 2022 | 4.22 Mn |
| Jun 30, 2022 | 3.54 Mn |
| Mar 31, 2022 | 278.65 Mn |
| Dec 31, 2021 | 3.86 Mn |
| Sep 30, 2021 | 3.47 Mn |